MassMutual Private Wealth & Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-410
Closed -$8.79K 1089
2017
Q2
$8.79K Sell
410
-2,130
-84% -$43K ﹤0.01% 755
2017
Q1
$43.5K Sell
2,540
-1,210
-32% -$21.1K ﹤0.01% 489
2016
Q4
$67.2K Buy
+3,750
New +$68K 0.01% 334
2016
Q2
$7.03M Sell
261,448
-3,390
-1% -$93K 0.89% 23
2016
Q1
$7.18M Buy
264,838
+40,632
+18% +$1.09M 0.97% 22
2015
Q4
$6.51M Buy
224,206
+81,578
+57% +$2.26M 0.93% 23
2015
Q3
$3.4M Buy
142,628
+16,056
+13% +$455K 0.72% 34
2015
Q2
$2.92M Sell
126,572
-54,266
-30% -$1.53M 0.65% 39
2015
Q1
$4.83M Buy
180,838
+23,144
+15% +$533K 0.8% 26
2014
Q4
$3.34M Buy
157,694
+15,066
+11% +$337K 1.08% 17
2014
Q3
$3.4M Buy
142,628
+16,056
+13% +$369K 0.68% 36
2014
Q2
$2.92M Buy
126,572
+33,430
+36% +$738K 1.16% 13
2014
Q1
$2.13M Buy
93,142
+38,112
+69% +$812K 1.24% 13
2013
Q4
$1.02M Buy
+55,030
New +$959K 0.94% 24

Other funds holding NVO

MassMutual Private Wealth & Trust's NVO Position: Q3 2017 in Review

MassMutual Private Wealth & Trust sold out of Novo Nordisk (NVO) in Q3 2017, closing a stake of 410 shares — an estimated $8.79K sold.

MassMutual Private Wealth & Trust first reported a position in NVO in Q4 2013 and held it in 14 quarters. The position peaked at $7.18M in Q1 2016. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

  • MassMutual Private Wealth & Trust reported no remaining Novo Nordisk position as of Q3 2017 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 410 Novo Nordisk shares in Q3 2017, an estimated $8.79K.
  • MassMutual Private Wealth & Trust first reported a position in Novo Nordisk in Q4 2013 and held it in 14 quarters.
  • MassMutual Private Wealth & Trust's Novo Nordisk position peaked at $7.18M in Q1 2016.
  • 491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2017, filed 13 Feb 2018.